drugset / Trial / NCT07456371
PIC1 Injection Therapy for Relapsed/Refractory B-NHL
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of PIC1 injection in the treatment of relapsed/refractory B-cell Non-Hodgkin Lymphoma.
Timeline
- Start
- 2026-03
- Primary completion
- 2026-12
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PIC1 Injection | Cell therapy | 1e+09 unknown | Intravenous |
| Subject | PIC1 Injection | Cell therapy | 2e+09 unknown | Intravenous |
| Subject | PIC1 Injection | Cell therapy | 4e+09 unknown | Intravenous |